|
Sep 7
|
Oncolytics Biotech® Announces Full Exercise of Over-Allotment Option from Public Offering
|
|
Sep 6
|
Oncolytics Biotech® to Participate in a Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference
|
|
Jun 22
|
Oncolytics Biotech's® Pelareorep Selected for Inclusion in Precision PromiseSM Pivotal Phase 3 Platform Trial
|